Literature DB >> 21841131

Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro.

Luka Mesin1, Roberto Di Niro, Keith M Thompson, Knut E A Lundin, Ludvig M Sollid.   

Abstract

To understand the biology of Ab-secreting cells in the human small intestine, we examined Ab production of intestinal biopsies kept in culture. We found sustained IgA and IgM secretion as well as viable IgA- or IgM-secreting cells after >4 wk of culture. The Ab-secreting cells were nonproliferating and expressing CD27 and CD138, thus having a typical plasma cell phenotype. Culturing of biopsies without tissue disruption gave the highest Ab production and plasma cell survival suggesting that the environment regulates plasma cell longevity. Cytokine profiling of the biopsy cultures demonstrated a sustained presence of IL-6 and APRIL. Blocking of the activity of endogenous APRIL and IL-6 with BCMA-Fc and anti-human IL-6 Ab demonstrated that both these factors were essential for plasma cell survival and Ab secretion in the biopsy cultures. This study demonstrates that the human small intestine harbors a population of nonproliferating plasma cells that are instructed by the microenvironment for prolonged survival and Ab secretion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841131     DOI: 10.4049/jimmunol.1003181

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  Regulation of intestinal IgA responses.

Authors:  Na Xiong; Shaomin Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-03       Impact factor: 9.261

2.  Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice.

Authors:  A Lemke; M Kraft; K Roth; R Riedel; D Lammerding; A E Hauser
Journal:  Mucosal Immunol       Date:  2015-05-06       Impact factor: 7.313

Review 3.  New concepts in the generation and functions of IgA.

Authors:  Oliver Pabst
Journal:  Nat Rev Immunol       Date:  2012-10-29       Impact factor: 53.106

4.  Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia.

Authors:  Julia M Shaw; Leia K Miller-Novak; Venkatramanan Mohanram; Katherine McKinnon; Thorsten Demberg; Diego A Vargas-Inchaustegui; David Venzon; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.

Authors:  M Jourdan; M Cren; N Robert; K Bolloré; T Fest; C Duperray; F Guilloton; D Hose; K Tarte; B Klein
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

Review 6.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

Review 7.  The human intestinal B-cell response.

Authors:  J Spencer; L M Sollid
Journal:  Mucosal Immunol       Date:  2016-07-27       Impact factor: 7.313

Review 8.  Plasma cells in immunopathology: concepts and therapeutic strategies.

Authors:  Benjamin Tiburzy; Upasana Kulkarni; Anja Erika Hauser; Melanie Abram; Rudolf Armin Manz
Journal:  Semin Immunopathol       Date:  2014-04-17       Impact factor: 9.623

9.  Rhesus macaque rectal and duodenal tissues exhibit B-cell sub-populations distinct from peripheral blood that continuously secrete antigen-specific IgA in short-term explant cultures.

Authors:  Michael A Thomas; Thorsten Demberg; Diego A Vargas-Inchaustegui; Peng Xiao; Iskra Tuero; David Venzon; Deborah Weiss; James Treece; Marjorie Robert-Guroff
Journal:  Vaccine       Date:  2013-12-25       Impact factor: 3.641

10.  Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients.

Authors:  Nick Willcox; Pilar Martinez-Martinez; Mario Losen; Alejandro M Gomez; Kathleen Vrolix; Jonas Hummel; Gisela Nogales-Gadea; Abhishek Saxena; Hans Duimel; Fons Verheyen; Peter C Molenaar; Wim A Buurman; Marc H De Baets
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.